Literature DB >> 28762317

Effects of Plasma Activated Medium on Head and Neck FaDu Cancerous Cells: Comparison of 3D and 2D Response.

Julie Chauvin1,2, Florian Judee1, Nofel Merbahi1, Patricia Vicendo2.   

Abstract

OBJECTIVE: The aim of this work is to investigate the inhibitory effect of Plasma Activated Medium (PAM) on Head and Neck cancerous cells (FaDu). The response of FaDu cells in monolayer cultures and Multi Cellular Tumor Spheroids (MCTS) after treatment with different PAMs will be compared.
BACKGROUND: Head and Neck squamous cell carcinoma is a widespread cancer that responds poorly to anticancer treatments such as chemotherapy and radiotherapy. Nowadays there is a growing interest in cold plasmas and their applications in cancer therapy.
METHODS: A homemade helium plasma jet is used to produce PAM. The effects of PAM and hydrogen peroxide H2O2 on FaDu 2D cells cultures and MCTS were characterized by evaluating the cell viability with PrestoBlue test and by measuring the size of MCTS.
RESULTS: One treatment with PAM induce cell detachment from MCTS since the first day in a PAM exposure dependent manner. This is due to the presence of H2O2 in PAM. However, a rapid spheroids regrowth is observed attributed to a resistance of FaDu cells to H2O2. After multiple treatments of MCTS with PAM we obtained an inhibition of cell growth. MCTS are brought out when comparing PAM effect on 2D versus MCTS. Inversely, PAM induces cell death in the case of 2D cell culture.
CONCLUSION: PAM may be considered as a potentially efficient agent in the therapy of head and neck cancer. We also point out that MCTS is a more valuable model than 2D cell culture for the evaluation of the anti-cancer activity of PAM. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  FaDu; Plasma medicine; cell viability; head & neck cancer; hydrogen peroxide; multi cellular tumorzzm321990spheroid; plasma activated medium.

Mesh:

Substances:

Year:  2018        PMID: 28762317     DOI: 10.2174/1871520617666170801111055

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  8 in total

1.  Cold Atmospheric Plasma-Activated Media Improve Paclitaxel Efficacy on Breast Cancer Cells in a Combined Treatment Model.

Authors:  Cosmin-Teodor Mihai; Ilarion Mihaila; Maria Antoanela Pasare; Robert Mihai Pintilie; Mitica Ciorpac; Ionut Topala
Journal:  Curr Issues Mol Biol       Date:  2022-04-30       Impact factor: 2.976

2.  Elucidation of in vitro cellular steps induced by antitumor treatment with plasma-activated medium.

Authors:  Julie Chauvin; Laure Gibot; Elena Griseti; Muriel Golzio; Marie-Pierre Rols; Nofel Merbahi; Patricia Vicendo
Journal:  Sci Rep       Date:  2019-03-19       Impact factor: 4.379

3.  Pulsed Electric Field Treatment Enhances the Cytotoxicity of Plasma-Activated Liquids in a Three-Dimensional Human Colorectal Cancer Cell Model.

Authors:  Elena Griseti; Jelena Kolosnjaj-Tabi; Laure Gibot; Isabelle Fourquaux; Marie-Pierre Rols; Mohammed Yousfi; Nofel Merbahi; Muriel Golzio
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

4.  Patient-Derived Human Basal and Cutaneous Squamous Cell Carcinoma Tissues Display Apoptosis and Immunomodulation following Gas Plasma Exposure with a Certified Argon Jet.

Authors:  Fariba Saadati; Juliane Moritz; Julia Berner; Eric Freund; Lea Miebach; Iris Helfrich; Ingo Stoffels; Steffen Emmert; Sander Bekeschus
Journal:  Int J Mol Sci       Date:  2021-10-23       Impact factor: 5.923

Review 5.  Open Questions in Cold Atmospheric Plasma Treatment in Head and Neck Cancer: A Systematic Review.

Authors:  Vittoria Perrotti; Vito Carlo Alberto Caponio; Lorenzo Lo Muzio; Eun Ha Choi; Maria Carmela Di Marcantonio; Mariangela Mazzone; Nagendra Kumar Kaushik; Gabriella Mincione
Journal:  Int J Mol Sci       Date:  2022-09-06       Impact factor: 6.208

Review 6.  Plasma oncology: Adjuvant therapy for head and neck cancer using cold atmospheric plasma.

Authors:  Xuran Li; Xiaoqing Rui; Danni Li; Yanhong Wang; Fei Tan
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

7.  Development of an in vitro cell-sheet cancer model for chemotherapeutic screening.

Authors:  Jaewang Lee; Daiha Shin; Jong-Lyel Roh
Journal:  Theranostics       Date:  2018-06-24       Impact factor: 11.556

8.  Reduction of Human Glioblastoma Spheroids Using Cold Atmospheric Plasma: The Combined Effect of Short- and Long-Lived Reactive Species.

Authors:  Angela Privat-Maldonado; Yury Gorbanev; Sylvia Dewilde; Evelien Smits; Annemie Bogaerts
Journal:  Cancers (Basel)       Date:  2018-10-23       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.